Brooks Laboratories Ltd Share Price

Q: What is the share price of Brooks Laboratories Ltd today?

Brooks Laboratories Ltd share price as on 12 Jun 2026 is ₹65.05

Pharmaceuticals

NSE: BROOKS Small Cap ISIN: INE650L01011

As on 13 June 2026 at 01:08 IST

₹65.05

+ 0.00

(0.00%)

Sell Buy

Over 1 Month

37.06%

Over 6 Months

-33.58%

Over 1 Year

-49.19%

Over 3 Years

4.58%

Brooks Laboratories Ltd Summary

Close ₹65.05

Open ₹68.25

High ₹68.25

Low ₹64.55

Volume 14,893

Net Turnover (in Cr) ₹0.098

52Wk High ₹164.02

52Wk Low ₹36.30

52Wk High / Low

36.30

164.02

Brooks Laboratories Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹191.62

EPS (TTM) 1.97

Book Value (BV) 41.02

Div. Yield -

P/E (TTM) 33.12

Price/Book Value 1.59

Delivery % -

Face Value 10

Key Ratios

PE Ratio 103.60

PB Ratio 2.76

EV to Sales 3.92

PEG Ratio 1.31

ROA 2.46

ROE 2.43

Debt-Equity 0.07

Net Profit Margin 3.69

Operating Profit Margin 7.10

Brooks Laboratories Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	83.44	80.40	63.42	91.99	77.98
Total Expenses	80.25	78.85	98.83	115.88	86.97
Profit Before Tax	-9.79	-19.57	-38.37	-23.90	-8.99
Profit After Tax	-9.97	-19.59	-31.05	-19.31	-19.38
Operating Profit After Depreciation	4.22	2.40	-33.23	-20.80	-5.89

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	13.98	13.67	15.01	110.01	107.71
Total Non Current Assets	89.82	59.40	81.99	134.73	114.72
Total Current Assets	33.88	31.05	27.61	61.18	47.36
Total Assets	123.69	90.45	109.60	195.91	162.08
Total Shareholder's Fund	98.10	65.59	73.95	87.49	79.15

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	2.63	-9.80	-14.49	-37.44	4.46
Net Cash Used In Investing Activities	-45.14	0.18	0.49	-24.91	-5.13
Net Cash Used In Financing Activities	42.43	9.72	11.41	64.07	1.16

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	83.44	80.40	55.65	77.91	78.23
Total Expenses	80.21	78.85	63.84	77.25	86.67
Profit Before Tax	3.23	1.55	-8.18	0.67	-8.44
Profit After Tax	3.05	1.53	-8.18	0.67	-15.59
Operating Profit After Depreciation	4.26	2.40	-7.42	1.34	-5.19

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	13.98	13.67	15.01	15.14	14.98
Total Non Current Assets	106.78	63.34	64.82	66.42	67.65
Total Current Assets	33.88	31.05	27.61	37.04	25.34
Total Assets	140.66	94.39	92.42	103.45	93
Total Shareholder's Fund	115.07	69.53	56.78	65	64.21

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	2.63	-9.80	0.55	3.12	-0.90
Net Cash Used In Investing Activities	-45.14	0.18	-0.40	1.12	-0.74
Net Cash Used In Financing Activities	42.43	9.72	-0.21	-4.23	1.31

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	20.21	16.57	23.45	25.51	23.32
Total Expenses	19.53	15.84	20.93	22.39	24.57
Profit Before Tax	1.53	5.51	7.98	9.58	-1.28
Profit After Tax	1.52	5.50	7.98	9.58	-1.46
Operating Profit after Depreciation	2.03	6.06	8.65	10.27	-0.63

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	20.21	16.57	23.45	25.51	23.32
Total Expenses	19.53	15.84	20.93	22.39	21.74
Profit Before Tax	0.62	0.31	2.24	2.65	1.55
Profit After Tax	0.61	0.30	2.24	2.65	1.37
Operating Profit after Depreciation	1.12	0.86	2.91	3.34	2.20

Brooks Laboratories Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 63.65

S2 62.25

S3 59.95

Pivot 65.95

R1 67.35

R2 69.65

R3 71.05

Moving Average

20 SMA 59.25

50 SMA 59.45

100 SMA 61.91

200 SMA 88.78

Brooks Laboratories Ltd Corporate Actions

No available data

AGM Date: 29 Sep 2021

AGM 29/09/2021 Proceedings of 19th Annual General Meeting of the Company held on 29th September 2021 Appointment of Mr. Manpreet Singh Naroo as a Whole Time Director designated as Technical Director and Mrs. Kaushalya Singh as a Whole Time Director. (As Per BSE Announcement Dated on 9/29/2021 5:28:17 AM) Voting Results alongwith Scrutinizers Report for the 19th AGM of the Company held on 29.019.2021 (As Per BSE Announcement Dated on 9/30/2021 6:12:53 AM)

AGM Date: 29 Sep 2022

AGM 29/09/2022 Book Closure is fixed for conducting 20th Annual General Meeting of Brooks Laboratories Limited. (As per BSE Announcement Dated on 7/9/2022) Proceedings of the 20th AGM of Brooks Laboratories Limited held on 29th September, 2022 Alteration in the Authorized Share Capital clause of the Memorandum of Association of the Company. (As Per BSE Announcement Dated on 29/09/2022)

AGM Date: 21 Sep 2023

Reg. 34 (1) Annual Report. Newspaper advertisement for conducting 21st AGM Notice of 21st AGM (As Per BSE Announcement Dated on 01/09/2023) Proceedings and Outcome of 21st AGM held on 21st September, 2023 at 9.00 am (As Per BSE Announcement Dated on 21/09/2023) Revised Proceedings and Outcome of 21st AGM held on 21st September, 2023. (As Per BSE Announcement dated on 06.04.2024)

AGM Date: 19 Sep 2024

AGM 19/09/2024 Intimation of Record Date, E-voting dates and Book Closure date. (As Per BSE Announcement dated on 28.08.2024) Outcome of AGM alongwith proceeding,voting results and scrutinizers report. (As Per BSE Announcement dated on 19.09.2024)

AGM Date: 26 Sep 2025

AGM 26/09/2025 Notice of 23rd Annual General Meeting of the Company to be held on Friday, 26th September 2025 at 9:00 A.M through VC/OAVM. Pursuant to Regulation 30 of SEBI (LODR) 2015, please find enclosed herewith a summary of the proceedings of the 23rd AGM. (As Per BSE Announcement Dated on:26.09.2025) Scrutinizer Report along with voting results for the AGM held on September 26, 2025 (As per BSE Announcement dated on: 27/09/2025)

Brooks Laboratories Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Brooks Laboratories Ltd Top Mutal Funds Invested

Fund Name	AUM
Quant Business Cycle Fund	1.87%

Brooks Laboratories Ltd News

Brooks Laboratories to convene board meeting

On 29 May 2026

25 May 2026, 10:10 am

Brooks Laboratories to conduct board meeting

On 6 February 2026

30 Jan 2026, 04:58 pm

Brooks Laboratories to declare Quarterly Results

On 14 November 2025

10 Nov 2025, 03:28 pm

Brooks Laboratories AGM scheduled

On 26 September 2025

09 Sep 2025, 12:58 pm

Brooks Laboratories to declare Quarterly Results

On 13 August 2025

08 Aug 2025, 03:17 pm

Brooks Laboratories Ltd Stock Analysis

Annual revenue for Brooks Laboratories Ltd increased by 3.78% to ₹83.44 crore in FY 2025 from ₹80.40 crore in FY 2024.
Annual Net Profit for Brooks Laboratories Ltd increased by 99.62% to ₹3.05 crore in FY 2025 from ₹1.53 crore in FY 2024.
Promoter Shareholding in Brooks Laboratories Ltd remains unchanged by 0.00% in the most recent quarter, from 52.62% in December 2025 to 52.62% in March 2026.
Brooks Laboratories Ltd delivered a 1-year return of -49.19% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Brooks Laboratories Ltd share price moved remains unchanged by 0.00% from its previous close of INR ₹65.05. The latest Brooks Laboratories Ltd share price is INR ₹65.05.
Brooks Laboratories Ltd share price today has been at a low of 65.05 and a high of 66.82. Over the past 52 weeks, the Brooks Laboratories Ltd share price has seen a low of 36.30 and a high of 164.02.